127 related articles for article (PubMed ID: 8545258)
1. NG-nitro-L-arginine methyl ester and alpha-methyl-L-ornithine inhibit kyotorphin synthetase from rat brain.
Kawabata A; Tanaka M; Muguruma H; Takagi H
Peptides; 1995; 16(7):1317-9. PubMed ID: 8545258
[TBL] [Abstract][Full Text] [Related]
2. Kyotorphin synthetase activity in rat adrenal glands and spinal cord.
Kawabata A; Muguruma H; Tanaka M; Takagi H
Peptides; 1996; 17(3):407-11. PubMed ID: 8735966
[TBL] [Abstract][Full Text] [Related]
3. Kinetic characteristics of nitric oxide synthase from rat brain.
Knowles RG; Palacios M; Palmer RM; Moncada S
Biochem J; 1990 Jul; 269(1):207-10. PubMed ID: 1695842
[TBL] [Abstract][Full Text] [Related]
4. Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results.
Salter M; Duffy C; Hazelwood R
Neuropharmacology; 1995 Mar; 34(3):327-34. PubMed ID: 7543191
[TBL] [Abstract][Full Text] [Related]
5. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
McCall TB; Feelisch M; Palmer RM; Moncada S
Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in the effect of nitric oxide synthase inhibition on L-arginine-induced insulin secretion.
Gross R; Roye M; Manteghetti M; Broca C; Hillaire-Buys D; Masiello P; Ribes G
Br J Pharmacol; 1997 Feb; 120(3):495-501. PubMed ID: 9031755
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis.
Mulligan MS; Moncada S; Ward PA
Br J Pharmacol; 1992 Dec; 107(4):1159-62. PubMed ID: 1281719
[TBL] [Abstract][Full Text] [Related]
8. Substantial regional and hemispheric differences in brain nitric oxide synthase (NOS) inhibition following intracerebroventricular administration of N omega-nitro-L-arginine (L-NA) and its methyl ester (L-NAME).
Salter M; Duffy C; Garthwaite J; Strijbos PJ
Neuropharmacology; 1995 Jun; 34(6):639-49. PubMed ID: 7566500
[TBL] [Abstract][Full Text] [Related]
9. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter.
Bogle RG; Moncada S; Pearson JD; Mann GE
Br J Pharmacol; 1992 Apr; 105(4):768-70. PubMed ID: 1380372
[TBL] [Abstract][Full Text] [Related]
10. Neural barriers affect the action of nitric oxide synthase inhibitors in the intact chicken retina.
Wellard JW; Miethke P; Morgan IG
Neurosci Lett; 1995 Dec; 201(1):17-20. PubMed ID: 8830302
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B
Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069
[TBL] [Abstract][Full Text] [Related]
12. Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase.
Robertson CA; Green BG; Niedzwiecki L; Harrison RK; Grant SK
Biochem Biophys Res Commun; 1993 Dec; 197(2):523-8. PubMed ID: 7505570
[TBL] [Abstract][Full Text] [Related]
13. N(G)-nitro-L-arginine and its methyl ester inhibit brain synthesis of kynurenic acid possibly via nitric oxide-independent mechanism.
Luchowski P; Kocki T; Urbańska EM
Pol J Pharmacol; 2001; 53(6):597-604. PubMed ID: 11985333
[TBL] [Abstract][Full Text] [Related]
14. Effects of kyotorphin (L-tyrosyl-L-arginine) ON[3H]NG-nitro-L-arginine binding to neuronal nitric oxide synthase in rat brain.
Arima T; Kitamura Y; Nishiya T; Taniguchi T; Takagi H; Nomura Y
Neurochem Int; 1997 Jun; 30(6):605-11. PubMed ID: 9153002
[TBL] [Abstract][Full Text] [Related]
15. Nitro containing L-arginine analogs interfere with assays for nitrate and nitrite.
Greenberg SS; Xie J; Spitzer JJ; Wang JF; Lancaster J; Grisham MB; Powers DR; Giles TD
Life Sci; 1995; 57(21):1949-61. PubMed ID: 7475944
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of L-N5-(1-iminoethyl)-ornithine on tone and endothelium-dependent vasodilator responses.
DeWitt BJ; Champion HC; Marrone JR; McNamara DB; Giles TD; Greenberg SS; Kadowitz PJ
Am J Physiol; 1997 Sep; 273(3 Pt 1):L588-94. PubMed ID: 9316493
[TBL] [Abstract][Full Text] [Related]
17. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
Rees DD; Palmer RM; Schulz R; Hodson HF; Moncada S
Br J Pharmacol; 1990 Nov; 101(3):746-52. PubMed ID: 1706208
[TBL] [Abstract][Full Text] [Related]
18. Effects of ornithine alpha-ketoglutarate on insulin secretion in rat pancreatic islets: implication of nitric oxide synthase and glutamine synthetase pathways.
Schneid C; Darquy S; Cynober L; Reach G; De Bandt JP
Br J Nutr; 2003 Feb; 89(2):249-57. PubMed ID: 12575909
[TBL] [Abstract][Full Text] [Related]
19. Possible role of nitric oxide in the development of L-2-chloropropionic acid-induced cerebellar granule cell necrosis.
Widdowson PS; Gyte A; Simpson MG; Farnworth M; Dunn D; Moore RB; Wyatt I; Lock EA
Br J Pharmacol; 1996 Apr; 117(8):1761-7. PubMed ID: 8732288
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms mediating NG-nitro-L-arginine methyl ester-induced hypophagia in mice.
Hui SC; Chan TY
Eur J Pharmacol; 1995 Sep; 283(1-3):141-50. PubMed ID: 7498303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
